98 related articles for article (PubMed ID: 8536760)
1. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome.
Uehara T; Kuwashima Y; Izumo T; Kishi K; Shiromizu K; Matsuzawa M
Eur J Gynaecol Oncol; 1995; 16(6):453-60. PubMed ID: 8536760
[TBL] [Abstract][Full Text] [Related]
2. [Aspects of Bcl-2 proto-oncogene expression in dysplastic and malignant lesions of the uterine cervix].
Borţun F; Chiovschi S; Moldovan M
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):821-6. PubMed ID: 16004225
[TBL] [Abstract][Full Text] [Related]
3. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
4. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
Padovan P; Salmaso R; Marchetti M; Padovan R
Eur J Gynaecol Oncol; 2000; 21(3):267-72. PubMed ID: 10949392
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
7. Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma.
Li Z; Takeuchi S; Ohara N; Maruo T
Int J Clin Oncol; 2003 Apr; 8(2):83-9. PubMed ID: 12720100
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
9. The relationship between expression of p53/bcl-2 and clinicopathological criteria in cervix squamous cell carcinomas.
Bitiren M; Cakmak EA; Gocmen A; Inaloz SS; Sari I; Karakok M; Aydin A
Eur J Gynaecol Oncol; 2003; 24(5):411-2. PubMed ID: 14584658
[TBL] [Abstract][Full Text] [Related]
10. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
[TBL] [Abstract][Full Text] [Related]
12. [Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer].
Harima Y; Oka A; Nagata K; Harima K; Tanaka Y; Shikata N
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1273-7. PubMed ID: 9703806
[TBL] [Abstract][Full Text] [Related]
13. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.
Eduardo MG; Campaner AB; Silva MA
Pathol Oncol Res; 2015 Sep; 21(4):887-92. PubMed ID: 25682239
[TBL] [Abstract][Full Text] [Related]
15. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kokawa K; Shikone T; Otani T; Nakano R
Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.
Sultana H; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Sato S; Kamazawa S; Ohwada M; Suzuki M; Terakawa N
Ann Oncol; 2003 Feb; 14(2):214-9. PubMed ID: 12562647
[TBL] [Abstract][Full Text] [Related]
19. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
